Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000–2021
Cancer · 2026
DOI: 10.1002/cncr.70217 ↗Kurz gefasst
Fachartikel in der Zeitschrift Cancer, 2026. Verfasst von Jaclyn LoPiccolo und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA. Hauptthemen laut MEDLINE: Lung Neoplasms, Carcinoma, Non-Small-Cell Lung. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 23 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar. Gefördert von: NHGRI NIH HHS, NCI NIH HHS, LUNGevity Foundation.
Abstract (Originalsprache)
Background
Although the incidence of several cancers diagnosed before age 50 years has increased, contemporary trends in early‐onset lung cancer remain poorly defined, particularly across histologic and sociodemographic subgroups.
Methods
A population‐based cohort study was conducted via Surveillance, Epidemiology, and End Results 22 Program registries of 81,568 individuals diagnosed with lung cancer at age 20–49 years from 2000 to 2021. Age‐adjusted incidence rates and annual percent change (APC) were estimated via National Cancer Institute Joinpoint regression. Overall trends were stratified by histology, sex, race/ethnicity, and state‐level smoking prevalence.
Results
From 2000 to 2021, early‐onset lung cancer incidence declined overall (average APC, −3.81%; 95% CI, −4.01% to −3.64%; p < .0001), which contrasts with rising early‐onset colorectal and female breast cancers. Declines among females occurred later but were steeper for lung adenocarcinoma (LUAD; −5.14% vs. −2.82%), whereas males declined faster for non–small cell lung cancer (NSCLC) and overall. Female declines were slower relative to males in Hispanic and non‐Hispanic (NH) Black individuals (2.3‐ and 1.08‐fold difference, respectively), whereas NH White females declined 1.3‐fold faster than males. Among Asian females, NSCLC incidence did not decline, and LUAD increased through 2017 (+2.45%) and remained stable in Hispanic females. In high‐smoking states, male rates declined steadily (−4.32%), whereas female rates were stable until 2010, then dropped sharply, and converged with males by 2021. In low‐smoking states, male rates declined 48.75% faster than female rates (−4.76% vs. −3.20%).
Conclusions
Early‐onset lung cancer incidence declined overall from 2000 to 2021, except for persistent or rising LUAD among Asian and Hispanic females, which implicates emerging non‐tobacco risk factors and highlights the need for targeted prevention.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- The Lowe Center for Thoracic Oncology, Dana-Farber Cancer Institute, Boston, Massachusetts, USA.
- Department of Medicine, Harvard Medical School, Boston, Massachusetts, USA.
- The Eli and Edythe L. Broad Institute, Cambridge, Massachusetts, USA.
- Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, Massachusetts, USA.
- Massachusetts General Hospital, Boston, Massachusetts, USA.
ORCID-Profile: Jaclyn LoPiccolo, Narjust Florez
Förderung
- NHGRI NIH HHS
- NCI NIH HHS
- LUNGevity Foundation
Zitieren
APA
LoPiccolo, J., Tramontano, A. C., Florez, N., Johnson, B. E., Gusev, A., Christiani, D. C., & Jänne, P. A. (2026). Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000–2021. Cancer. https://doi.org/10.1002/cncr.70217
Vancouver
LoPiccolo J, Tramontano AC, Florez N, Johnson BE, Gusev A, Christiani DC, et al. Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000–2021. Cancer. 2026. doi:10.1002/cncr.70217
BibTeX
@article{LoPiccolo2026,
author = {LoPiccolo, Jaclyn and Tramontano, Angela C and Florez, Narjust and Johnson, Bruce E and Gusev, Alexander and Christiani, David C and Jänne, Pasi A},
title = {Patterns of lung cancer incidence in adults diagnosed under age 50 in the United States, 2000–2021},
journal = {Cancer},
year = {2026},
doi = {10.1002/cncr.70217}
}
EUVIMED